Maunsell Farris Maryanne 4
4 · HAEMONETICS CORP · Filed May 17, 2023
Insider Transaction Report
Form 4
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Transactions
- Award
Common Stock
2023-05-15+630→ 630 total - Award
Non-qualified Stock Option (Right to Buy)
2023-05-15+1,425→ 1,425 totalExercise: $89.16Exp: 2030-05-15→ Common Stock (1,425 underlying)
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.